Veterinary Medicines

Insol Dermatophyton Zawiesina do wstrzykiwań

Authorised
  • Trichophyton verrucosum, strain 410, Inactivated
  • Trichophyton mentagrophytes, strain 551, Inactivated
  • Trichophyton equinum, strain 381, Inactivated
  • Trichophyton mentagrophytes, strain 1032, Inactivated
  • Microsporum canis, strain 1393, Inactivated
  • Microsporum distortum, strain 120, Inactivated
  • Microsporum canis, strain 1311, Inactivated
  • Nannizzia gypsea, strain 59, Inactivated
Download as PDF

Product identification

Medicine name:
Insol Dermatophyton Zawiesina do wstrzykiwań
Active substance:
  • Trichophyton verrucosum, strain 410, Inactivated
  • Trichophyton mentagrophytes, strain 551, Inactivated
  • Trichophyton equinum, strain 381, Inactivated
  • Trichophyton mentagrophytes, strain 1032, Inactivated
  • Microsporum canis, strain 1393, Inactivated
  • Microsporum distortum, strain 120, Inactivated
  • Microsporum canis, strain 1311, Inactivated
  • Nannizzia gypsea, strain 59, Inactivated
Target species:
  • Cat
  • Horse
  • Dog
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Trichophyton verrucosum, strain 410, Inactivated
  • Trichophyton mentagrophytes, strain 551, Inactivated
  • Trichophyton equinum, strain 381, Inactivated
  • Trichophyton mentagrophytes, strain 1032, Inactivated
  • Microsporum canis, strain 1393, Inactivated
  • Microsporum distortum, strain 120, Inactivated
  • Microsporum canis, strain 1311, Inactivated
  • Nannizzia gypsea, strain 59, Inactivated
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI05AQ02
  • QI06AQ01
  • QI07AQ01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Wirtschaftsgenossenschaft deutscher Tieraerzte eG
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 1405
Date of authorisation status change:

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/01/2025
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/01/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/01/2025
Download